Eleonora Nicolò

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Lymph Node Metastasis

Metastatic Breast Cancer

Top Venues

Journal of personalized medicine

JCO precision oncology

JCO oncology practice

Expert review of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Eleonora Nicolò, Laura Munoz-Arcos, Elena Vagia, Paolo D'Amico, Giancarlo Feliciello, Jeannine Donahue, Marco Lorico-Rappa, Maroua Manai, Amir Behdad, Youbin Zhang, Giuseppe Curigliano, Ami N Shah, Massimo Cristofanilli
Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of FGFR2-KIAA1598 Gene Fusion. JCO precision oncology 7 (2023)
Chiara Corti, Federica Giugliano, Eleonora Nicolò, Paolo Tarantino, Carmen Criscitiello, Curigliano Giuseppe
HER2-Low Breast Cancer: a New Subtype? Current treatment options in oncology (2023)
Paola Zagami, Dario Trapani, Eleonora Nicolò, Chiara Corti, Carmine Valenza, Carmen Criscitiello, Curigliano Giuseppe, Lisa Anne Carey
Cardiotoxicity of Agents Used in Patients With Breast Cancer. JCO oncology practice (2023)
Carla Corvaja, Beatrice Taurelli Salimbeni, Eleonora Nicolò, Fabio Puglisi, Curigliano Giuseppe
Deciding on the best pharmacotherapy for advanced triple-negative breast cancer: expert guidance. Expert opinion on pharmacotherapy 23 (16) (2022)
Liliana Ascione, Paola Zagami, Eleonora Nicolò, Edoardo Crimini, Curigliano Giuseppe, Carmen Criscitiello
PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative. Journal of personalized medicine 12 (11) (2022)
Jacopo Uliano, Eleonora Nicolò, Carla Corvaja, Beatrice Taurelli Salimbeni, Dario Trapani, Curigliano Giuseppe
Combination immunotherapy strategies for triple-negative breast cancer: current progress and barriers within the pharmacological landscape. Expert review of clinical pharmacology 15 (12) (2022)
Liliana Ascione, Paola Zagami, Eleonora Nicolò, Edoardo Crimini, Curigliano Giuseppe, Carmen Criscitiello
PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative. Journal of personalized medicine 12 (11) (2022)